Assessing Disease Activity in Psoriatic Arthritis: A Literature Review
- PMID: 30471015
- PMCID: PMC6393266
- DOI: 10.1007/s40744-018-0132-4
Assessing Disease Activity in Psoriatic Arthritis: A Literature Review
Abstract
Psoriatic arthritis (PsA) is a multifaceted disease, with a high impact on patients' psychological and physical well-being. There is increasing recognition that assessment of both clinical aspects of disease and patient identified concerns, such as fatigue, work disability, and treatment satisfaction need to be addressed. Only then can we fully understand disease burden and make well-informed treatment decisions aimed at improving patients' lives. In recent years, there has been much progress in the development of unidimensional and composite measures of disease activity, as well as questionnaires capturing the patient's perspective in psoriatic disease. Despite these advances, there remains disagreement amongst clinicians as to which instruments should be used. As a consequence, they are yet to receive widespread implementation in routine clinical practice. This review aims to summarize currently available clinical and patient-derived assessment tools, which will provide clinicians with a practical and informative resource.
Keywords: Composite measures; Disease activity; Impact of disease; Outcome measures; Patient perspective; Psoriatic arthritis; Treatment satisfaction; Work disability.
Similar articles
-
Assessment of the many faces of PsA: single and composite measures in PsA clinical trials.Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i29-i36. doi: 10.1093/rheumatology/kez305. Rheumatology (Oxford). 2020. PMID: 32159792 Free PMC article. Review.
-
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.Ann Rheum Dis. 2014 Jun;73(6):1012-9. doi: 10.1136/annrheumdis-2014-205207. Ann Rheum Dis. 2014. PMID: 24790067
-
Functional impairment measurement in psoriatic arthritis: Importance and challenges.Semin Arthritis Rheum. 2018 Dec;48(3):436-448. doi: 10.1016/j.semarthrit.2018.05.010. Epub 2018 May 23. Semin Arthritis Rheum. 2018. PMID: 30029795 Review.
-
Filling the "GAP" in Real-World Assessment of Psoriatic Arthritis Disease Activity: Performance Characteristics of a Global/Pain Composite Endpoint.Rheumatol Ther. 2024 Oct;11(5):1101-1114. doi: 10.1007/s40744-024-00690-1. Epub 2024 Jul 2. Rheumatol Ther. 2024. PMID: 38955921 Free PMC article.
-
PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis.Rheumatol Ther. 2023 Apr;10(2):489-505. doi: 10.1007/s40744-022-00518-w. Epub 2022 Dec 30. Rheumatol Ther. 2023. PMID: 36585602 Free PMC article.
Cited by
-
Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children.J Am Acad Dermatol. 2020 May;82(5):1187-1194. doi: 10.1016/j.jaad.2020.01.023. Epub 2020 Jan 21. J Am Acad Dermatol. 2020. PMID: 31972257 Free PMC article.
-
Prevalence of psoriatic arthritis among patients with plaque psoriasis: a Brazilian retrospective study.Sao Paulo Med J. 2021 Aug-Sep;139(5):476-480. doi: 10.1590/1516-3180.2020.0629.16032021. Sao Paulo Med J. 2021. PMID: 34378736 Free PMC article.
-
Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis.RMD Open. 2023 Oct;9(4):e002972. doi: 10.1136/rmdopen-2022-002972. RMD Open. 2023. PMID: 37880177 Free PMC article.
-
Assessment of the many faces of PsA: single and composite measures in PsA clinical trials.Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i29-i36. doi: 10.1093/rheumatology/kez305. Rheumatology (Oxford). 2020. PMID: 32159792 Free PMC article. Review.
-
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.RMD Open. 2022 Jul;8(2):e002366. doi: 10.1136/rmdopen-2022-002366. RMD Open. 2022. PMID: 35863864 Free PMC article.
References
-
- Coates LC, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheumatol. 2016;68(5):1060–1071. - PubMed
-
- Gossec L, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous